Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer

Clinical trial NCT01411072 · UNKNOWN

Trial details

NCT number: NCT01411072
Sponsor: AHS Cancer Control Alberta
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Pancreas Cancer

Start date: 2011-09-01
Primary completion: 2015-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.